293 related articles for article (PubMed ID: 2668913)
1. Covalent and noncovalent protein binding of drugs: implications for hepatic clearance, storage, and cell-specific drug delivery.
Meijer DK; van der Sluijs P
Pharm Res; 1989 Feb; 6(2):105-18. PubMed ID: 2668913
[TBL] [Abstract][Full Text] [Related]
2. The influence of binding to albumin and alpha 1-acid glycoprotein on the clearance of drugs by the liver.
Meijer DK; Van der Sluijs P
Pharm Weekbl Sci; 1987 Apr; 9(2):65-74. PubMed ID: 3295762
[TBL] [Abstract][Full Text] [Related]
3. Extrapolation of the Hepatic Clearance of Drugs in the Absence of Albumin In Vitro to That in the Presence of Albumin In Vivo: Comparative Assessement of 2 Extrapolation Models Based on the Albumin-Mediated Hepatic Uptake Theory and Limitations and Mechanistic Insights.
Poulin P; Haddad S
J Pharm Sci; 2018 Jul; 107(7):1791-1797. PubMed ID: 29567347
[TBL] [Abstract][Full Text] [Related]
4. Extrapolation of In Vivo Hepatic Clearance from In Vitro Uptake Clearance by Suspended Human Hepatocytes for Anionic Drugs with High Binding to Human Albumin: Improvement of In Vitro-to-In Vivo Extrapolation by Considering the "Albumin-Mediated" Hepatic Uptake Mechanism on the Basis of the "Facilitated-Dissociation Model".
Kim SJ; Lee KR; Miyauchi S; Sugiyama Y
Drug Metab Dispos; 2019 Feb; 47(2):94-103. PubMed ID: 30504137
[TBL] [Abstract][Full Text] [Related]
5. Determination of hepatic clearance with the account of drug-protein binding kinetics.
Berezhkovskiy LM
J Pharm Sci; 2012 Oct; 101(10):3936-45. PubMed ID: 22767378
[TBL] [Abstract][Full Text] [Related]
6. Influence of plasma protein binding kinetics on hepatic clearance assessed from a "tube" model and a "well-stirred" model.
Jansen JA
J Pharmacokinet Biopharm; 1981 Feb; 9(1):15-26. PubMed ID: 7229915
[TBL] [Abstract][Full Text] [Related]
7. Hepatic elimination of drugs with concentration-dependent serum protein binding.
Huang JD; Oie S
J Pharmacokinet Biopharm; 1984 Feb; 12(1):67-81. PubMed ID: 6747819
[TBL] [Abstract][Full Text] [Related]
8. The corrected traditional equations for calculation of hepatic clearance that account for the difference in drug ionization in extracellular and intracellular tissue water and the corresponding corrected PBPK equation.
Berezhkovskiy LM
J Pharm Sci; 2011 Mar; 100(3):1167-83. PubMed ID: 21355107
[TBL] [Abstract][Full Text] [Related]
9. Commentary: a physiological approach to hepatic drug clearance.
Wilkinson GR; Shand DG
Clin Pharmacol Ther; 1975 Oct; 18(4):377-90. PubMed ID: 1164821
[TBL] [Abstract][Full Text] [Related]
10. Binding of drugs to alpha 1-acid glycoprotein and its desialylated form. Influence on hepatic disposition and implications for drug targeting to the liver.
Meijer DK; van der Sluijs P
Prog Clin Biol Res; 1989; 300():143-67. PubMed ID: 2674961
[No Abstract] [Full Text] [Related]
11. [Hepatic clearance of drugs. Physiological and pharmacokinetic considerations].
Pellegrin P; Lesne M
J Pharmacol; 1983; 14(2):107-39. PubMed ID: 6865443
[TBL] [Abstract][Full Text] [Related]
12. Comparative Assessment of Extrapolation Methods Based on the Conventional Free Drug Hypothesis and Plasma Protein-Mediated Hepatic Uptake Theory for the Hepatic Clearance Predictions of Two Drugs Extensively Bound to Both the Albumin And Alpha-1-Acid Glycoprotein.
Bteich M; Poulin P; Haddad S
J Pharm Sci; 2021 Mar; 110(3):1385-1391. PubMed ID: 33217427
[TBL] [Abstract][Full Text] [Related]
13. The potential protein-mediated hepatic uptake: discussion on the molecular interactions between albumin and the hepatocyte cell surface and their implications for the in vitro-to-in vivo extrapolations of hepatic clearance of drugs.
Bteich M; Poulin P; Haddad S
Expert Opin Drug Metab Toxicol; 2019 Aug; 15(8):633-658. PubMed ID: 31274340
[No Abstract] [Full Text] [Related]
14. Effect of chronic renal failure on the disposition of highly hepatically metabolized drugs.
Yuan R; Venitz J
Int J Clin Pharmacol Ther; 2000 May; 38(5):245-53. PubMed ID: 10839468
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of hepatic clearance prediction using in vitro data: emphasis on fraction unbound in plasma and drug ionisation using a database of 107 drugs.
Hallifax D; Houston JB
J Pharm Sci; 2012 Aug; 101(8):2645-52. PubMed ID: 22700322
[TBL] [Abstract][Full Text] [Related]
16. A physiologically based pharmacokinetic model to predict the pharmacokinetics of highly protein-bound drugs and the impact of errors in plasma protein binding.
Ye M; Nagar S; Korzekwa K
Biopharm Drug Dispos; 2016 Apr; 37(3):123-41. PubMed ID: 26531057
[TBL] [Abstract][Full Text] [Related]
17. Membrane transport in hepatic clearance of drugs. II: Zonal distribution patterns of concentration-dependent transport and elimination processes.
Kwon Y; Morris ME
Pharm Res; 1997 Jun; 14(6):780-5. PubMed ID: 9210197
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption.
Shitara Y; Maeda K; Ikejiri K; Yoshida K; Horie T; Sugiyama Y
Biopharm Drug Dispos; 2013 Jan; 34(1):45-78. PubMed ID: 23115084
[TBL] [Abstract][Full Text] [Related]
19. Direct determination of the ratio of unbound fraction in plasma to unbound fraction in microsomal system (fu p/fu mic) for refined prediction of phase I mediated metabolic hepatic clearance.
Deshmukh SV; Harsch A
J Pharmacol Toxicol Methods; 2011; 63(1):35-9. PubMed ID: 20433934
[TBL] [Abstract][Full Text] [Related]
20. Prediction of total hepatic clearance by combining metabolism, transport, and permeability data in the in vitro-in vivo extrapolation methods: emphasis on an apparent fraction unbound in liver for drugs.
Poulin P
J Pharm Sci; 2013 Jul; 102(7):2085-95. PubMed ID: 23613473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
